Novartis Pharmaceuticals Canada Inc.
Registration:
24
of
38
(2019-03-01
to
2019-05-01)
Senior Officers whose lobbying activities represent less than 20% of their Duties
-
Thea Discepola,
Interim President
Senior Officers and Employees whose lobbying activities represent 20% or more of their Duties
-
Shona Kinley,
Director, Federal Policy & Government Affairs
| Public offices held